In accordance to our results, it has also been demonstrated that HIF-1α enhances tumor-initiating cell frequency in vivo in part by regulation of the expression of CD133 and the Notch pathway in breast cancer cells [34]. This evidence concerns the gene HIF1A and breast cancer.